ScopeSys Overview

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.1M

  • Investors
  • 8

ScopeSys General Information

Description

Developer of imaging analytics technology designed to characterize genetic medicines and nucleic acid-based therapeutics. The company offers real-time particle imaging technology, benchtop instruments, consumables, and analytical services, enabling pharmaceutical companies and biotechnology organizations to analyze freely diffusing molecules and particles under biologically relevant conditions.

Contact Information

Website
www.scopesys.ca
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2222 Health Sciences Mall
  • Vancouver, British Columbia V6T 1Z3
  • Canada
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Vertical(s)
Corporate Office
  • 2222 Health Sciences Mall
  • Vancouver, British Columbia V6T 1Z3
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ScopeSys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 01-Apr-2026 $1.1M Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
1. University Spin-Out 01-Jan-2015 Completed Generating Revenue
To view ScopeSys’s complete valuation and funding history, request access »

ScopeSys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of imaging analytics technology designed to characterize genetic medicines and nucleic acid-based therapeutics
Other Pharmaceuticals and Biotechnology
Vancouver, Canada
7 As of 2026

Xiamen, China

Signal Hill, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ScopeSys Competitors (2)

One of ScopeSys’s 2 competitors is NanoFCM, a Venture Capital-Backed company based in Xiamen, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NanoFCM Venture Capital-Backed Xiamen, China
Spectradyne Accelerator/Incubator Backed Signal Hill, CA
You’re viewing 2 of 2 competitors. Get the full list »

ScopeSys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ScopeSys Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hextwo Capital Venture Capital Minority
The University of British Columbia University Minority
VentureUs Angel Group Minority
WUTIF Capital Angel Group Minority
Xavaav Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

ScopeSys FAQs

  • Where is ScopeSys headquartered?

    ScopeSys is headquartered in Vancouver, Canada.

  • What is the size of ScopeSys?

    ScopeSys has 7 total employees.

  • What industry is ScopeSys in?

    ScopeSys’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is ScopeSys a private or public company?

    ScopeSys is a Private company.

  • What is ScopeSys’s current revenue?

    The current revenue for ScopeSys is .

  • How much funding has ScopeSys raised over time?

    ScopeSys has raised $1.1M.

  • Who are ScopeSys’s investors?

    Hextwo Capital, The University of British Columbia, VentureUs, WUTIF Capital, and Xavaav Capital are 5 of 8 investors who have invested in ScopeSys.

  • Who are ScopeSys’s competitors?

    NanoFCM and Spectradyne are competitors of ScopeSys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process